Norito Fukuda

Norito Fukuda

Auto-generated profile, based on publicly available information

Norito Fukuda

Neuroprotection Research Laboratory, Department of Radiology Massachusetts General Hospital and Harvard Medical School Charlestown Massachusetts USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
Wenlu LiWenlu Li
Wenlu Li
Emiri T. MandevilleEmiri T. Mandeville
Emiri T. Mandeville
VDVioleta Durán-Laforet
Violeta Durán-Laforet
NFNorito Fukuda
Norito Fukuda
ZYZhanyang Yu
Zhanyang Yu
ELEng Lo
Eng Lo
The concept of the neurovascular unit emphasizes the importance of cell-cell signaling between neural, glial, and vascular compartments. In neurogenesis, for example, brain endothelial cells play a key role by supplying trophic support to neural progenitors. Here, we describe a surprising phenomenon where brain endothelial cells may release trans-differentiation signals that convert astrocytes into neural progenitor cells in male mice after stroke. After oxygen-glucose deprivation, brain endothelial cells release microvesicles containing pro-neural factor Ascl1 that enter into astrocytes to induce their trans-differentiation into neural progenitors. In mouse models of focal cerebral ischemia, Ascl1 is upregulated in endothelium prior to astrocytic conversion into neural progenitor cells. Injecting brain endothelial-derived microvesicles amplifies the process of astrocyte trans-differentiation. Endothelial-specific overexpression of Ascl1 increases the local conversion of astrocytes into neural progenitors and improves behavioral recovery. Our findings describe an unexpected vascular-regulated mechanism of neuroplasticity that may open up therapeutic opportunities for improving outcomes after stroke.

25 November 2022 in World Neurosurgery
Verified
Journal Article
Closed access
TTToru Tateoka
Toru Tateoka
HYHideyuki Yoshioka
Hideyuki Yoshioka
KKKazuya Kanemaru
Kazuya Kanemaru
TWTakuma Wakai
Takuma Wakai
KHKoji Hashimoto
Koji Hashimoto
HKHiroyuki Kinouchi
Hiroyuki Kinouchi

1 January 2024 in Bioinformatics and Biology Insights
Verified
Journal Article
Open access
THTomonori Hoshino
Tomonori Hoshino
HTHajime Takase
Hajime Takase
HIHidehiro Ishikawa
Hidehiro Ishikawa
GHGen Hamanaka
Gen Hamanaka
SKShintaro Kimura
Shintaro Kimura
KAKen Arai
Ken Arai
A-kinase anchor protein 12 (AKAP12), a scaffold protein, has been implicated in the central nervous system, including blood-brain barrier (BBB) function. Although its expression level in the corpus callosum is higher than in other brain regions, such as the cerebral cortex, the role of AKAP12 in the corpus callosum remains unclear. In this study, we investigate the impact of AKAP12 deficiency by transcriptome analysis using RNA-sequencing (RNA-seq) on the corpus callosum of AKAP12 knockout (KO) mice. We observed minimal changes, with only 13 genes showing differential expression, including Akap12 itself. Notably, Klf2 and Sgk1, genes potentially involved in BBB function, were downregulated in AKAP12 KO mice and expressed in vascular cells similar to Akap12. These changes in gene expression may affect important biological pathways that may be associated with neurological disorders. Our findings provide an additional data set for future research on the role of AKAP12 in the central nervous system.

1 June 2020 in World Neurosurgery
Verified
Journal Article
Closed access
NFNorito Fukuda
Norito Fukuda
TYTakashi Yagi
Takashi Yagi
KKKazuya Kanemaru
Kazuya Kanemaru
HYHideyuki Yoshioka
Hideyuki Yoshioka
KHKoji Hashimoto
Koji Hashimoto
HKHiroyuki Kinouchi
Hiroyuki Kinouchi

30 December 2024 in World Neurosurgery
Verified
Journal Article
Open access
NFNorito Fukuda
Norito Fukuda
HYHideyuki Yoshioka
Hideyuki Yoshioka
MOMasakazu Ogiwara
Masakazu Ogiwara
KHKoji Hashimoto
Koji Hashimoto
TWTakuma Wakai
Takuma Wakai
HKHiroyuki Kinouchi
Hiroyuki Kinouchi
Bifrontal craniotomy is one of the most common surgical approaches for dealing with anterior skull base lesions. However, this procedure occasionally presents complications like anosmia, cerebrospinal fluid (CSF) leakage, infection, and cosmetic problems. Although previous reports suggested various solutions, there remains a need to further refine the procedure to ensure better outcomes. In this paper, we introduce our revised method and examine the clinical results. Our protocol pays attention to preventing avulsion of the olfactory bulb by brain movement, such as avoiding preoperative administration of hyperosmotic diuretic solution, mobilizing the olfactory tract from the frontal lobe base, and fixing the olfactory bulb to the cribriform plate. On opening, the frontal sinus mucosa is separated from the bone components and pushed into the frontonasal duct. After removing the inner table, the frontal sinus is completely covered by the pericranial flap. To prevent cosmetic problems, a Gigli wire saw is used to cut the supraorbital edge to minimize the bone defect. Surgical complications in 38 patients who underwent bifrontal craniotomy using these methods in our institute from 2005 to 2020 were investigated. Only 1 case (2.6%) experienced postoperative anosmia. There were no cases of CSF leakage, infections, or cosmetic problems. Through diligent practices and attention to minute details, such as gentle manipulations to preserve the olfactory nerve, reliable procedures for frontal sinus closure, and maximum attention to esthetic results, surgical techniques can be refined and developed to the level of highly skilled expertise with low rate of complications.

17 August 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
MDMunehiro Demura
Munehiro Demura
PGPenelope Gregory
Penelope Gregory
NFNorito Fukuda
Norito Fukuda
ELEng H. Lo
Eng H. Lo
KAKen Arai
Ken Arai
Background: Circadian rhythms regulate sleep–wake cycles, hormonal secretion, metabolism, and immune responses. Disruption of these rhythms is linked to the onset and progression of various neurological diseases. Emerging evidence suggests that exercise, a non‐photic zeitgeber, can modulate circadian function at both central and peripheral levels by regulating core clock gene expression, synchronizing hormonal and metabolic rhythms, and reducing neuroinflammation. Through these mechanisms, exercise enhances the amplitude, stability, and phase alignment of circadian rhythms and may promote physiological resilience. Review: This review summarizes the molecular and systemic mechanisms through which exercise supports circadian homeostasis and discusses their relevance to stroke and Alzheimer's disease. In both conditions, circadian misalignment contributes to pathological processes including oxidative stress, neuroinflammation, and impaired neurovascular repair. By restoring circadian alignment, appropriately timed exercise may improve neurological outcomes through effects on neuroplasticity, immune regulation, and metabolic synchronization. Summary: Taken together, current evidence may suggest that exercise can be a promising non‐pharmacological strategy to enhance circadian resilience, reduce disease vulnerability, and support neurological recovery.